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Abstract
In this study, we investigated the pH sensitivity of different liposomal formulations containing 10 mol% N-stearoylcys-
teamine, as pH sensitive molecule. Liposome stability was monitored by determining the release of different entrapped
 .water soluble molecules, 5,6-carboxyfluorescein CF being the marker of leakage mainly used. Small unilamellar vesicles
 .  .composed of egg phosphatidylcholine EPC and N-stearoylcysteamine 9:1 molar ratio incubated at 208C in citrate
phosphate buffer released, at pH 6.8, 2.5 fold the amount of CF released at pH 7.4. The addition of plasma to the incubation
medium and an increase of temperature to 378C led to significantly increased the CF release from EPCrN-stearoylcystea-
mine SUV, both at pH 7.4 and 6.8. The addition of cholesterol had a stabilizing effect on liposomal vesicles with respect to
both temperature and plasma, without affecting pH sensitivity. In fact, at 378C and in 25% plasma the ternary mixture
showed the highest CF release, as a consequence of the moderate acidification of the medium from 7.4 to 6.8. Thus, these
liposome formulations are potentially a useful tool for specific drug delivery to pathological tissues such as tumours,
inflammation sites and ischemic areas where it is known that a lowering of the pH can occur. q 1997 Elsevier Science B.V.
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1. Introduction
The general strategy for constructing pH-sensitive
liposomes has been to include in the bilayer lipids
containing pH-sensitive groups such N-palmitoyl-
 . w xhomocysteine PHC 1–3 , cholesterylhemisuccinate
w x  .4 , oleic acid OA with phosphatidylethanolamine
 . w xPE as auxiliary lipid 5–7 , N-succinyldioleoyl
w xphosphatidylethanolamine 8 , diacylsuccinylglyc-
w x w xerols 7,9 and tocopherol hemisuccinate 10 . These
molecules have the ability to destabilize the lipid
) Corresponding author. Fax: q39-2-2363584.
bilayer when exposed to an acidic environment, with
a consequent release of water soluble trapped
molecules.
Although the potential use of pH-sensitive lipo-
wsomes remains to be evaluated, in vitro studies 1,11–
x15 indicate that they are effective in enhancing the
cytoplasmatic delivery of trapped molecules to target
cells, as a consequence of their association with the
acidic environment of cellular endosomes and lyso-
somes.
An important application of pH sensitive lipo-
somes is represented by their possible use for selec-
tive drug release to those pathological tissues such as
tumours, metastases, inflammation sites and ischemic
0005-2736r97r$17.00 q 1997 Elsevier Science B.V. All rights reserved.
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areas that have an ambient pH considerably lower
than that of normal tissues.
The in vivo application requires the definition of
pH sensitive formulations relatively stable in circulat-
ing fluids at physiological pH, but able to release
encapsulated drugs in response to an acidification of
w xsurrounding medium 9,16 . The use of amphipatic
molecules containing SH as the pH sensitive group
w xwas widely investigated 1–3,17 , but unfortunately
many of the reported pH sensitive liposomal formula-
tions are not sufficiently stable andror do not main-
tain the pH sensitivity in plasma. In this study, we
investigated the pH sensitivity of different liposomal
formulations containing 10 mol% N-stearoylcystea-
mine as the pH sensitive molecule, using different
water soluble molecules as markers of leakage.
For liposomal formulations that exhibited a marked
pH sensitivity in buffer, we also evaluated the plasma
stability at pH 7.4, together with the capacity to
maintain a sensitivity to moderate plasma pH drop
 .i.e., 6.8 .
2. Materials and methods
2.1. Chemicals
Analytical grade chemicals, distilled solvents and
doubly distilled water were used. Egg phosphatidyl-
choline, cholesterol, dipalmitoylphosphatidylcholine,
5,6-carboxyfluorescein, calcein, and NADH were
purchased from Sigma, Sepharose 4B from Pharma-
 .cia, 1-palmitoyl-2- 10-pyrene decanoyl phosphatidyl-
 .choline and 12- 1-pyrene dodecanoic acid were ob-
tained from Molecular Probe. D-14C-glucose and
3H-inulin from Amersham and the liquid scintillation
 .counting mixture Ultimagold from Packard.
2.1.1. Chemical syntheses
General. All melting points are uncorrected. 1H-
 .NMR spectra 500 MHz were recorded on a Bruker
AM-500 instrument in CDCl and are reported in d3
units relative to CHCl fixed at 7.24 ppm. TLC was3
performed on precoated silica gel G plates Merck,
.HF ; spots were visualised by spraying with 70%254
sulphuric acid and heating.
( )2.1.2. Synthesis of the N-stearoylcysteamine 1
A mixture of cystamine dihydrochloride 4.5 g, 20
.  .mmol , stearoyl chloride 12.12 g, 40 mmol , 4-
 .  .N, N-dimethylamino pyridine 0.5 g and pyridine
 .100 ml was stirred at room temperature for 24 h.
The reaction mixture was then poured into a stirred
 . mixture of brine 100 g and aqueous HCl 250 ml, 6
.M . The resulting solid was filtered, washed with
water and dried. Crystallisation from ethanol afforded
 . the pure N, N-distearoylcystamine 2 9.86 g, 72%
. yield : mp 132–1338C; TLC eluent CH Cl –MeOH2 2
. 1 100:5 v:v , R s0.38; H-NMR: d 6.17 2H, t,f
. Js6.0 Hz, 2=NH , 3.55 4H, dt, Js6.0 and 6.0
. Hz, 2=NH–CH – , 2.81 4H, t, Js6.0 Hz, 2= –2
.  .CH –S , 2.19 4H, t, Js7.5 Hz, 2= –CH CO and2 2
 .0.86 6H, t, Js7.0 Hz, 2= –CH . Anal. Calcd. for3
C H N O S : C, 70.12; H, 11.77; N, 4.09. Found:40 80 2 2 2
C, 69.76; H, 11.52; N, 4.21.
 .A mixture of compound 2 5 g, 7.3 mmol , acetic
 .  .acid 250 ml and zinc dust 5 g was refluxed under
vigorous stirring for 30 min. At this time it was
cooled to room temperature and 1,2-dichloroethane
 .250 ml was added. The resulting mixture was fil-
tered and the solution was evaporated under reduced
pressure to afford a residue which was tritured with
 .MeOH–H O 100 ml 1:1, v:v . The suspension was2
filtered and the crude product obtained was crys-
 .tallised from ethanol to give 4.2 g 84% yield of the
 . N-stearoylcysteamine 1 : mp 88–908C; TLC eluent
. 1CH Cl –MeOH 100:5 v:v , R s0.52; H-NMR: d2 2 f
 . 5.80 1H, t, Js6.0 Hz, NH , 3.42 2H, dt, Js6.0
. and 6.0 Hz, NH–CH – , 2.65 2H, dt, Js8.5 and2
. 6.0 Hz, –CH –SH , 2.17 2H, t, Js7.5 Hz,2
.  . CH CO , 1.31 1H, t, Js8.5 Hz, SH and 0.86 6H,2
.t, Js7.0 Hz, –CH ; mass spectrum: mrz 3433
 q.  .  .  .1.76, M , 284 12.50 , 267 1.58 , 171 1.34 , 149
 .  .  .8.64 , 137 7.98 and 119 15.5 . Anal. Calcd. for
C H NOS: C, 69.91; H, 12.03; N, 4.08. Found: C,20 41
70.12; H, 11.87;, N, 3.95.
[ ( )2.1.3. Synthesis of N- 12- 1-pyrenyl dodeca-
] ( )noyl cysteamine 3
 . A solution of 12- 1-pyrenyl dodecanoic acid 20
.  .mg in thionyl chloride 1 ml containing dimethyl-
 .formamide 10 ml was refluxed for 1 h and then
evaporated under reduced pressure. The residue was
 .dissolved in toluene 2 ml and evaporated under
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reduced pressure twice for a complete removal of
thionyl chloride. The residue was dissolved in pyri-
 . dine 1 ml containing 4- N , N-dimethyl-
.  .amino pyridine 2 mg and reacted with cystamine
 .dihydrochloride 20 mg . The solution was stirred at
room temperature for 48 h and then poured into a
 . stirred mixture of brine 1 g and aqueous HCl 2.5
.  .ml, 6 M . Extraction with AcOEt, drying Na SO2 4
and removal of the solvent under reduced pressure
afforded a crude product which was purified by TLC
 .eluent CH Cl –MeOH 100:10 v:v, R s0.55 , to2 2 f
w  . xgive the N, N-di- 12- 1-pyrenyl dodecanoyl cysta-
 .  . 1 mine 4 15 mg : H-NMR: d 8.96 2H, d, Js9.5
.  . Hz , 8.67 2H, d, Js8.3 Hz , 8.31–8.26 6H, over-
.  . lapping , 8.195 2H, d, Js9.0 Hz , 8.19 2H, d,
.  . Js7.5 Hz , 8.085 2H, t, Js7.5 Hz , 8.08 2H, d,
.  . Js9.0 Hz , 6.17 2H, t, Js6.0 Hz , 3.55 4H, dt,
.  .Js6.0 and 6.0 Hz, , 2.81 4H, t, Js6.0 Hz, and
 .2.19 4H, t, Js7.5 Hz .
 .A stirred mixture of compound 4 10 mg , acetic
 .  .acid 1 ml and zinc dust 20 mg was refluxed for 30
min, cooled to room temperature, diluted with
 .dichloroethane 2 ml , filtered and evaporated to
dryness. The residue was purified by TLC eluent
.CH Cl –MeOH 100:5 v:v, R s0.45 to afford 6 mg2 2 f
w  . x  . 1of N- 12- 1-pyrenyl dodecanoyl cysteamine 3 ; H-
 . NMR: d 8.97 1H, d, Js9.5 Hz , 8.69 1H, d,
.  . Js8.2 Hz , 8.34–8.29 3H, overlapping , 8.22 2H,
.  . d, Js8.5 Hz , 8.12 1H, d, Js8.5 Hz , 8.11 1H, t,
.  . Js7.5 Hz , 5.80 1H, t, Js6.0 Hz , 3.42 2H, dt,
. Js6.0 and 6.0 Hz , 2.65 2H, dt, Js8.5 and 6.0
.  .Hz , 2.17 2H, t, Js7.5 Hz .
2.2. Preparation of liposomes
 .Small unilamellar vesicles SUVs of egg phos-
 .phatidylcholine EPC , dipalmitoylphosphatidyl-
 .choline DPPC or EPCrcholesterol containing or
not 10 mol% of N-stearoylcysteamine were prepared
w xby sonication as previously described 18 . Large
 .unilamellar vesicles LUVs of the same lipid compo-
sition were prepared by reverse-phase evaporation as
w xdescribed by Szoka et al. 19 .
2.3. Light scattering measurements
Light scattering experiments were carried out with
a Jasco FP777 spectrophotofluorimeter. The Raleigh
peak from unpolarized incident light at 450 nm was
measured to monitor the 908 light scattering of lipid
suspension. The data are expressed as ArA , where0
A is the light scattering of reference sample and A0
that of the analysed sample.
2.4. Trapped ˝olume determinations
The volumes of internal, solute available, aqueous
compartments of vesicles considered here, were de-
 .termined by ‘trapping’ 5,6-carboxyfluorescein CF .
Vesicles containing trapped marker were prepared by
sonication of lipids in 10 mM Tris–HCl pH 7.4, 100
 .mM CF or other water soluble molecules and gel
filtration through a 1,5=18 Sepharose 4B column at
room temperature using as elution buffer 10 mM
citric acid, 20 mM Na HPO , 154 mM NaCl pH 7.4.2 4
Trapped CF was determined fluorimetrically at 520
nm with excitation at 490 nm, after the rupture of
 .chromatographed vesicles with SDS 1% wrv final
concentration.
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The molar concentration of phospholipids in the
vesicle sample was determined according to Bartlett
w x20 ; the molar concentration of cholesterol was de-
termined using a reagent kit for Boehringer
Mannheim.
The trapped aqueous volume was calculated as:
V s M rM rP .t i 0
where V is expressed as ml of trapped volume pert
mmol of vesicle lipid, M and M are concentrationsi 0
of trapped solute in the chromatographed vesicle
sample and the sonication buffer, respectively, and P
is the molar concentration of lipids in the vesicle
sample.
2.5. Liposome stability determinations
The stability of liposomes was monitored by deter-
mining the time-dependent leakage of CF from lipo-
somes with different lipid composition prepared in 10
 .mM Tris–HCl pH 7.4 , 100 mM CF and separated
from extra vesicular CF by gel filtration on Sepharose
4B. The CF containing vesicles were eluted with 10
mM citric acid, 20 mM Na HPO , 154 mM NaCl pH2 4
7.4. 100 ml of eluted vesicles, corresponding to 20
nmol of lipids, were then diluted to 1.0 ml with the
elution buffer at pH 7.4 or 6.8 with or without 25%
human plasma. Fluorescence emission at 520 nm was
 .determined zero time fluorescence, F setting the0
excitation wavelength at 490 nm. The increase in the
fluorescence emission of CF, a highly fluorescent
substance which undergoes a concentration depen-
w xdent selfquenching 21 , was monitored by measuring
the time dependent leakage of this molecule from
liposomes. The data are expressed as:
%CF releases100= FyF r F yF .  .0 t 0
were F is the fluorescence intensity at the given time
and F is the total CF fluorescence measured after thet
rupture of vesicles with SDS 1% final concentration.
The procedure described above for CF, was also
used to determine the liposome stability using calcein
as the water soluble trapped molecule.
The pH-dependent stability of liposomes was also
determined using 14C-glucose, 3H-inulin and NADH
as trapped molecules. In this case, vesicles containing
one of these markers, previously separated from the
extra vesicular one, were incubated for 30 min in the
elution buffer at pH 7.4 or 6.8. At the end of incuba-
tion the vesicles were separated by gel filtration on
Sepharose 4B using 10 mM citric acid, 20 mM
Na HPO , 154 mM NaCl at pH 7.4 as elution buffer;2 4
1 ml fractions were collected and each fraction ana-
lyzed for lipid and trapped molecule content. NADH
was determined fluorimetrically Ex ls340 nm;
.Em ls460 nm . Liposome stability determinations
were done at least in triplicate.
2.6. Membrane fluidity
The membrane fluidity of different liposomes con-
taining N-stearoylcysteamine was evaluated by mea-
 .suring the fluorescence anisotropy r of 1,6-di-s
 .phenyl-1,3,5-hexatriene DPH as a function of tem-
w xperature 22 .
2.7. Excimer to monomer ratio determinations
The possible fusion of vesicles, containing
NC SH, as a consequence of a moderate drop in pH18
 .values i.e., 6.8 was evaluated by determining the
 .  .excimer 475 nm to monomer 379 nm fluorescence
 .intensity ratio ErM of P PC at different times of10
incubation. For this purpose small unilamellar vesi-
 .cles of EPC or EPCrNC SH, 9:1 molar ratio were18
 .labelled with P PC 10 mol% of total lipid .10
The distribution of NC SH in EPC small unil-18
amellar vesicles was evaluated by monitoring the
fluorescence emission spectrum of a pyrene acyl
 .derivative of cysteamine, namely N-12- 1-pyrenyl
dodecanoyl cysteamine NPC SH, molecule 3 in the12
.scheme of synthesis that represented 10 mol% of
total liposomal lipids. Concentrations of NPC SH in12
SUVs were determined by extracting liposomes eluted
from a Sepharose 4B column, with 20 vol of
 .CHCl rCH OH 2:1 v:v and reading the fluores-3 3
cence in the lipid extract using NPC SH or free12
pyrene standard solutions for the calibration curves.
2.8. Fluorescence measurements
All fluorescence measurements were carried out
with a Jasco FP777 spectrofluorimeter equipped with
a cuvette holder, the temperature being monitored by
a Haake GD3 thermostatic circulating bath and moni-
tored with a Subline PT 100 digital thermometer.
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3. Results
Trapped volume determinations and gel chro-
matography profiles determined by light scattering
 .measurements data not shown indicated that the
presence of 10 mol% NC SH did not alter the18
structural properties of EPC small unilamellar vesi-
 .cles SUVs . Higher molar concentrations of NC SH18
had a destabilizing effect on these liposomal formula-
tions which resulted in aggregation and a poor repro-
 .ducibility of their elution profiles data not shown .
The trapped volumes determined with CF loaded
vesicles were 0.63"0.08 and 0.716"0.09 for EPC
 .and EPCrNC SH 9:1 mrm small unilamellar18
vesicles, respectively.
The kinetics of CF release from EPC and
EPCrNC SH vesicles at 208C are reported in Fig. 1.18
The spontaneous CF release from EPC vesicles at pH
7.4 showed a biphasic kinetics with an initial fast
leakage in the first 5 min, followed by a more
prolonged slow release which was monitored for 45
min. The spontaneous release of CF from EPC small
unilamellar vesicles was very low, only 3.8% of
entrapped molecule being released after 30 min. The
kinetics evaluated with the same vesicles at pH 6.8
are almost identical to those obtained at pH 7.4 data
.not shown .
The presence of 10 mol% EPCrNC SH in EPC18
vesicles determined a partial destabilization of the
vesicle bilayer, which resulted in an increase of
spontaneous leakage of entrapped CF at pH 7.4. The
acidification of the medium at pH 6.8 promoted a
strong increase in the CF release from EPC vesicles
containing NC SH. At all the considered times, the18
CF diffusion, from EPCrNC SH containing vesi-18
cles, was 2.5-fold higher at pH 6.8 than at 7.4, thus
indicating that NC SH promotes a pH sensitivity in18
these liposomal formulations.
The pH-dependent increase in CF leakage could
depend on liposomal fusion promoted by the acidifi-
cation of the incubation medium. To ascertain this
possibility we incubated EPCrNC SH SUVs con-18
taining 10 mol% P PC with a large excess of non-10
fluorescent SUVs of the same lipid composition. The
ability of pyrene to form excimer with a characteris-
tic shift in the fluorescence spectrum has, in fact,
been used to demonstrate membrane fusion: Probe
 .P PC was incorporated into the bilayer of the10
 .Fig. 1. Extent of spontaneous carboxifluorescein CF release
 .from EPC SUVs v at pH 7.4 and from EPCrNC SH SUVs18
 .  .  .9:1 molar ratio at pH 7.4 B and 6.8 q respectively. Data
are expressed as % CF release calculated as described in Section
2. Data reported are the means of at least three experiments.
donor vesicles at excimerising concentrations i.e., 10
.mol% of total lipids . Labelled vesicles were then
mixed with unlabelled vesicles. Fusion of the vesicles
gives the pyrene derivative a greater area in which to
diffuse, reducing the number of excimers formed and
thus reducing the ErM ratio. We monitored the
ErM ratio, at pH 7.4 and 6.8, for the same time
period used for CF release determinations. ErM did
not vary in these experimental conditions data not
.shown , thus excluding possible vesicle fusion at
acidic pH.
In order to elucidate the contribution of the head
group interactions to the pH sensitivity observed with
EPC vesicles containing NC SH, the CF release of18
 .EPCrNC SH SUVs 9:1 molar ratio was evaluated18
in the presence of 500 mM NaCl, 500 mM urea, 25
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Fig. 2. Extent of CF release from EPCrNC SH SUVs 9:118
.  .molar ratio after 30 min of incubation at pH 7.4 I and 6.8
 .B in presence of NaCl 500 mM, urea 500 mM, reducing
glutathione 25 mM or ascorbate 200 mM. Data are expressed as
% CF release calculated as described in Section 2. Data reported
are the means"SD of at least three experiments.
mM GSH or 200 mM ascorbate. The % of CF release
after 30 min of incubation at pH 7.4 or 6.8 is reported
in Fig. 2. The pH sensitivity was maintained in the
presence of reducing agents like GSH and ascorbate,
or in presence of high ionic strength obtained with
NaCl. In contrast, urea determined an increase in CF
leakage at pH 7.4 from vesicles containing NC SH.18
The amount of CF released after 30 min at pH 7.4,
was similar to that released at pH 6.8. None of the
molecules considered affected the permeability of
 .pure EPC vesicles at both pHs data not shown .
The distribution of NC SH in the EPC bilayer18
was evaluated using EPC SUVs containing 10 mol%
w  . xof N - 12- 1-pyrenyl dodecanoyl cysteam ine
 .NPC SH . The fluorescence emission spectra of12
liposomal dispersions at pH 7.4 or 6.8 are shown in
Fig. 3. The spectra at both the pH considered are
characterized by the presence of two emission peaks
at 379 and 399 nm, that correspond to the typical
fluorescence emission pattern of non-interacting
pyrene molecules. The absence of an additional peak
in the region of 470 nm, that corresponds to fluores-
cence emission of excimer-forming aggregates, indi-
cated that all NPC SH molecules are present in the12
bilayer in monomeric form, thus indicating the ab-
sence of local enriched domains of NC SH in the18
EPC bilayer at both considered pHs.
In order to investigate whether or not the structural
modifications at the basis of the pH sensitivity of
these liposomal formulations are a reversible phe-
nomenon, we incubated EPCrNC SH SUVs for 518
min at pH 6.8, then the pH of incubation medium
 .was brought up to 7.4 Fig. 4B . In a parallel experi-
ment vesicles of the same lipid composition were
incubated for 5 min at pH 7.4, then the pH was
 .lowered to 6.8 Fig. 4A . In both cases the rate of CF
release responded to changes in the pH of the incuba-
tion medium.
The influence of the physicochemical state of the
bilayer was evaluated using SUVs composed of DPPC
 .and NC SH 9:1 mrm that have a gel to liquid18
Fig. 3. Fluorescence emission spectra of EPC SUVs containing
 .  .10 mol% of NPC SH at pH 7.4 and 6.8 - - - .12
Excitation wavelengths343 nm.
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 .  .  .Fig. 4. Extent of CF release from EPCrNC SH SUVs 9:1 molar ratio preincubated at pH 7.4 B , after lowering x the pH of18
 .  .  .  .  .incubation medium to 6.8 v panel A or preincubated at pH 6.8 v after increasing › the pH of incubation medium up to 7.4 B
 .panel B . In panels A and B, the kinetics of CF release from vesicles not submitted to pH changes are also reported. Data are expressed
as %CF release calculated as described in Section 2. Data reported are the means of at least three experiments.
 .phase transition at about 408C T , as determinedc
 .from r vs. temperature curves Fig. 5B . The times
dependent CF release observed at 258C, i.e., below
T , was similar and negligible at both the pH consid-c
ered. When the same liposomal formulations were
incubated above T , i.e., at 458C, we obtained ac
 .  .  .  .Fig. 5. A Extent of CF release from DPPCr NC SH SUVs 9:1 molar ratio incubated at 258C at pH 7.4 v and 6.8 I or at 458C at18
 .  .pH 7.4 q and 6.8 B . Data are expressed as % CF release calculated as described in Section 2. Data reported are the means of at least
 .  .three experiments. B Fluorescence polarisation measurements of 1,6-diphenyl-1,3,5-hexatriene DPH . The steady state anisotropy, r ,s
calculated as described in Section 2, was continuously monitored vs. temperature.
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Fig. 6. Extent of release of trapped molecules of different molec-
 .ular weight from EPCrNC SH SUVs 9:1 molar ratio after 3018
 .  .min of incubation at pH 7.4 I and 6.8 B . Data are expressed
as % of release of trapped molecules calculated as described
Section 2. Data reported are the means of at least three experi-
ments.
time-dependent CF release at pH 6.8 higher than at
 .pH 7.4 Fig. 5A . After 30 min of incubation at 458C,
DPPCrNC SH SUV released 26% and 67% of en-18
trapped CF at pH 7.4 and 6.8, respectively. This
seems to indicate that NC SH promotes a significant18
response to slight pH variations only in membranes
in the fluid state.
We also investigated if the pH sensitivity of lipo-
somes containing NC SH could depend on the na-18
ture of water soluble molecule trapped within the
aqueous compartment. For this purpose, CF was sub-
stituted with 14C-glucose. This molecule does not
permit a continuous monitoring of its release from
EPCrNC SH vesicles, thus the 14C-glucose concen-18
tration associated to liposomes was evaluated radio-
metrically after 30 min incubation of 14C-glucose-
loaded liposomes at pH 7.4 and 6.8. The liposome
associated 14C-glucose was 5.2 and 4.45 dpm nmoly1
lipid at pH 7.4 and 6.8, respectively, the initial
liposomal 14C-glucose concentration being 5.7 dpm
nmoly1 lipid. The about 2.5-fold 14C-glucose leakage
at pH 6.8 compared to that determined at pH 7.4, is
in good agreement with the data obtained with CF-
 .loaded liposomes Fig. 6 . Release of calcein, NADH
and 3H-inulin, from EPCrNC SH SUV after 30 min18
of incubation at pH 7.4 and 6.8 was also determined
 .Fig. 6 . The release of molecules with molecular
weight greater than CF was very low at both pH
considered, thus indicating a size selectivity leakage
of molecules from EPCrNC SH SUV.18
The potential use in vivo of these pH sensitive
liposomal formulations depends on their plasma sta-
bility and on the maintenance of the pH sensitivity in
plasma. The plasma stability of EPCrNC SH SUV18
was evaluated incubating at 378C CF-loaded vesicles
at different pHs in 25% human plasma. The use of
25% plasma dilution was based on previous evidence
 .  .  .Fig. 7. Extent of CF release from EPCrCholrNC SH SUVs 6:3:1 molar ratio in buffer at pH 7.4 q and 6.8 B incubated at 258C18
 .  .  .  .  .panel A or at 378C panel B and in 25% human plasma at pH 7.4 v and 6.8 l incubated at 378C panel B . Data are expressed as
%CF release calculated as described in Section 2. Data reported are the means of at least three experiments.
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w x23 that indicates that almost all the effects observ-
able in full plasma are found even in 25% plasma.
The addition of 25% plasma to the incubation medium
and the increase of temperature determined a signifi-
cant increase of CF release from vesicles both at pH
7.4 and 6.8. After 30 min of incubation, the CF
release at pH 7.4 and 6.8 was 46 and 58%, respec-
tively. The considerable increase in CF leakage at pH
7.4 makes these liposomal formulations unsuitable
for an in vivo utilization. It is known that cholesterol
strongly influences lipid membrane properties and
when incorporated into pH-sensitive liposomes it in-
w xcreases their stability at neutral pH values 5 . Thus,
we investigated the effect of the addition of choles-
terol to EPCrNC SH SUV on their plasma stability18
and pH sensitivity.
Kinetics of CF release from EPCrCholrNC SH18
 .SUV 6:3:1 molar ratio were determined at 258C
 .Fig. 7A . These vesicles are still pH sensitive in
buffer but the presence of cholesterol strongly stabi-
lizes the vesicles at both the pHs considered. In fact,
after 30 min of incubation at pH 7.4 and 6.8 the CF
released represented 2.4 and 8.5%, respectively.
Kinetics of CF release from EPCrCholrNC SH18
SUVs were also determined at 378C in the presence
 .or absence of 25% human plasma Fig. 7B . The CF
release observed at pH 7.4 and 6.8 at this temperature
was not strongly affected by the presence of 25%
plasma. In fact after 30 min of incubation at pH 6.8 it
was 2–2.6 fold that released at pH 7.4 irrespective of
the presence of 25% plasma. The trapped volume of
this liposomal formulation was 0.63 " 0.06 ml
y1  .mmol of lipids ns5 . At 378C, 50 mol% of
cholesterol further stabilized SUVs containing
 .NC SH both at pH 7.4 and 6.8 data not shown .18
Thus, reducing the amount of trapped molecule re-
leased in consequence to an acidification of the
medium.
 .EPCrCholrNC SH 6:3:1 molar ratio SUVs18
were incubated at 378 5 min at pH 6.8, then the pH of
the medium was brought up to 7.4. The rate of CF
release responded to changes in the pH of the incuba-
tion medium also in the presence of plasma data not
.shown .
In order to increase the volume of entrapped aque-
ous space per mol of lipid, we prepared large unil-
amellar vesicles of EPCrCholrNC SH 6:3:1 molar18
.ratio by reverse-phase evaporation. The trapped vol-
Fig. 8. Extent of 14C-glucose release from SUVs or LUVs of
 .EPCrCholrNC SH 6:3:1 molar ratio after 30 min of incuba-18
 .  .tion in 25% human plasma at 378C at pH 7.4 I and 6.8 B .
ume of these LUVs was 7.4"0.66 ml mmoly1 of
 .lipids ns5 , but the release after 30 min of incuba-
tion at 378C in 25% plasma at pH 7.4 and 6.8 of
14 .trapped molecule C-glucose was 60% and 70%,
 .respectively Fig. 8 . The decrease in stability at both
the considered pH make LUVs unsuitable for selec-
tive drug release.
4. Discussion
In this study, we investigated the pH sensitivity of
different liposomal formulations containing 10 mol%
N-stearoylcysteamine as the pH sensitive molecule,
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using different water soluble molecules as markers of
leakage. For liposomal formulation that exhibited pH
sensitivity in buffer, we also evaluated the plasma
stability at pH 7.4 together with the capacity to
maintain a sensitivity to a moderate drop in plasma
 .pH i.e., 6.8 .
The results demonstrated that NC SH promotes18
pH sensitivity in citric acidrNa HPO buffer in dif-2 4
ferent liposomal formulations using CF as marker of
leakage. The increased release of CF at pH 6.8 is not
due to the leakage resulting from the conversion of
CF to the non-ionized form by Hq ions because pK
of CF is more than two units below the pH used.
Furthermore the results obtained with 14C-glucose
loaded liposomes clearly indicate that the pH sensi-
tivity of EPCrNC SH liposomes is independent of18
the ionic nature of the trapped molecule.
The pH sensitivity promoted by NC SH does not18
depend on liposomal fusion, as demonstrated by the
pyrene ErM based membrane fusion assay per-
formed at pH 7.4 and 6.8. Furthermore, the sensitiv-
ity to changes in the pH of the medium demonstrated
for liposomes containing NC SH excluded any pos-18
sible contribution of liposomal fusion to that phe-
nomenon.
The results obtained in the presence of urea Fig.
.2 indirectly suggest that a rearrangement of hydro-
gen bonds at the surface of the bilayer could con-
tribute to the pH sensitivity associated with these
liposomal formulations.
A contribution of modification in the redox status
of NC SH and in the electrostatic interactions at the18
level of the head groups to the pH sensitivity of these
liposomes can also be excluded. In fact, significant
differences observed in CF leakage at pH 6.8 vs. 7.4
were maintained when the release was determined in
the presence of reducing agents such as GSH and
ascorbate or NaCl 500 mM concentration able to
.decrease the strength of electrostatic interactions
 .Fig. 2 .
The decrease in pH of the incubation medium
determined a size selective permeability of the lipo-
some bilayer. In fact, only the water soluble molecules
trapped within the aqueous compartment with molec-
 14 .ular weight lower than 400 i.e., CF and C-glucose
 .were released from EPCrNC SH SUVs Fig. 6 .18
This behaviour is not related to the formation of
NC SH enriched domains in EPC membranes be-18
cause the fluorescence emission spectra obtained with
 .N-acylsteamine carrying a pyrene group NPC SH12
did not show a peak in the region of 470 nm, that
corresponds to the fluorescence emission of
 .excimer-forming aggregates Fig. 3 . The defect
points generated in the bilayer as a consequence of
lowering the pH could depend on a rearrangement of
the NC SH head group. In fact at pH 6.8, SH is18
prevalently in a undissociated form, thus increasing
the possibility of intramolecular hydrogen bonds.
The potential use in vivo of pH sensitive liposome
formulations depends on their plasma stability and on
the maintenance of the pH sensitivity in plasma
w x15,16 . The addition of plasma to the incubation
medium and the increase of temperature from 25 to
378C determined a significant increase of CF release
from EPCrNC SH SUVs at both pH 7.4 and 6.8.18
The addition of cholesterol to the binary mixture
stabilizes the vesicles in the presence of plasma at pH
 .7.4 without modifying their pH sensitivity Fig. 7 . In
fact, at 378C and in 25% plasma the ternary mixture
showed the highest increase in CF release as a conse-
quence of the moderate acidification of the medium
from 7.4 to 6.8; moreover the pH sensitivity of
EPCrCholrNC SH SUVs in plasma responded to18
variations of the pH of the medium, as observed for
EPCrNC SH liposomes in buffer.18
In order to increase the volume of entrapped aque-
ous space per mole of lipid, we used large unilamel-
lar vesicles, but observed a decrease in stability of
LUVs at both pHs considered; this is in agreement
w xwith Liu et al. 24,25 who demonstrated that the
increase of vesicle curvature, by using small unil-
 .amellar liposomes dF200 nm in which the inser-
tion of stabilizing serum apoprotein is favoured, in-
crease the plasma stability of pH sensitive liposomes.
The behaviour of EPCrCholrNC SH SUVs in18
the presence of plasma makes this liposomal formula-
tion the most promising for possible clinical applica-
tions. From our results with plasma in vitro, we could
in fact predict that drug release from these liposomes
will be significantly increased if the liposomes pass
through a region with a pH lower than physiological.
Thus, these liposomes could become a clinically rele-
vant means of drug delivery to pathological tissues
such as tumoral tissues, inflammation or infection
sites and ischemic areas in which it is well known
that a lowering of the pH can occur.
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